Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06599684
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-13
Brief Title:
Study of INV-102 Ophthalmic Solution in Adults With Non-center Involved Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Phase 2a Pilot Open Label Multicenter Study of INV-102 Ophthalmic Solution in Subjects With Non-center Involved Diabetic Macular Edema NCIDME Associated With Non-proliferative Diabetic Retinopathy NPDR
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Phase 2 study to assess the efficacy of topically administered eyedrops of INV-102 during a 12-week dosing period in subjects with non-center involved DME NCIDME associated with NPDR
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None